October 28, 2020

Follow Up Results on First Multicenter Trial to Report Outcomes of Salvage Low Dose Radiotherapy Brachytherapy after External Beam Radiotherapy for Prostate Cancer

Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (EBRT) for patients with low-to-intermediate risk prostate cancer reported late Grade 3 gastrointestinal and genitourinary adverse events (AEs) occurring in 14% of trial participants.

Read the study